Acromegaly and pregnancy.

[1]  S. Ezzat,et al.  Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature , 2012, Clinical endocrinology.

[2]  P. Chanson,et al.  Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. , 2010, The Journal of clinical endocrinology and metabolism.

[3]  P. Chanson,et al.  Female gonadal function before and after treatment of acromegaly. , 2010, The Journal of clinical endocrinology and metabolism.

[4]  M. Molitch.  Prolactinomas and pregnancy , 2010, Clinical endocrinology.

[5]  P. Bernard,et al.  Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women , 2010, Clinical endocrinology.

[6]  N. Sicolo,et al.  Effects of octreotide exposure during pregnancy in acromegaly , 2010, Clinical endocrinology.

[7]  R. Murray,et al.  A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. , 2008, The Journal of clinical endocrinology and metabolism.

[8]  J. Verhaeghe.  Does the Physiological Acromegaly of Pregnancy Benefit the Fetus? , 2008, Gynecologic and Obstetric Investigation.

[9]  E. Forsum,et al.  Longitudinal Study of the Maternal Insulin-Like Growth Factor System before, during and after Pregnancy in Relation to Fetal and Infant Weight , 2007, Hormone Research in Paediatrics.

[10]  S. Weinzimer,et al.  Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  G. Ramanathan,et al.  IVF/ICSI in a woman with active acromegaly: Successful outcome following treatment with pegvisomant , 2006, Journal of Assisted Reproduction and Genetics.

[12]  C. Schmid,et al.  Pregnancy‐induced changes in insulin‐like growth factor I (IGF‐I), insulin‐like growth factor binding protein 3 (IGFBP‐3), and acid‐labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess , 2006, Acta obstetricia et gynecologica Scandinavica.

[13]  R. Attanasio,et al.  Pregnancy in acromegaly: a one-center experience. , 2006, European journal of endocrinology.

[14]  D. Rabinowitz,et al.  Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[15]  J. Bevan.  Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly. , 2005, The Journal of clinical endocrinology and metabolism.

[16]  K. Ho,et al.  Estrogen regulation of growth hormone action. , 2004, Endocrine reviews.

[17]  M. Bronstein,et al.  Medical Management of Pituitary Adenomas: The Special Case of Management of the Pregnant Woman , 2004, Pituitary.

[18]  M. Molitch.  Pituitary tumors and pregnancy. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[19]  M. Molitch,et al.  Timing and special concerns regarding endocrine surgery during pregnancy. , 2003, Endocrinology and metabolism clinics of North America.

[20]  O. Serri,et al.  Successful Pregnancy in a Woman With Acromegaly Treated With Octreotide Long-acting Release , 2003 .

[21]  N. Mikhail.  Octreotide treatment of acromegaly during pregnancy. , 2002, Mayo Clinic proceedings.

[22]  M. Fassnacht,et al.  Octreotide LAR® treatment throughout pregnancy in an acromegalic woman , 2001, Clinical endocrinology.

[23]  J. M. Neal,et al.  Successful pregnancy in a woman with acromegaly treated with octreotide. , 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[24]  J. J. Mukherjee,et al.  Menstrual irregularity in women with acromegaly. , 1999, The Journal of clinical endocrinology and metabolism.

[25]  S. Melmed,et al.  Pregnancy in acromegaly: successful therapeutic outcome. , 1998, The Journal of clinical endocrinology and metabolism.

[26]  P. Caron,et al.  Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. , 1997, The Journal of clinical endocrinology and metabolism.

[27]  A. Colao,et al.  Extensive personal experience: Acromegaly , 1997 .

[28]  P. Caron,et al.  Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). , 1996, The Journal of clinical endocrinology and metabolism.

[29]  J. Foidart,et al.  Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. , 1990, The Journal of clinical endocrinology and metabolism.

[30]  D. Gianola,et al.  Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201–995 and bromocriptine , 1990, Journal of endocrinological investigation.

[31]  G. Elizondo,et al.  Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. , 1988, American Journal of Medicine.

[32]  K. Paschkis,et al.  Acromegaly and pregnancy. , 1954, The Journal of clinical endocrinology and metabolism.